Overview

Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease

Status:
NOT_YET_RECRUITING

Trial end date:
2028-09-30

Target enrollment:

Participant gender:

Summary

The goal of this clinical trial is to describe which type and dose of commonly used heart rate reducing drugs (metoprolol, atenolol, or ivabradine) has the swiftest heart rate reduction from baseline in patients aged 30 to 80 years with a heart rate \> 65 beats per minute undergoing cardiac computed tomography for the evaluation of coronary artery disease. The main question it aims to answer is Which type of heart reducing drug and dose has the swiftest heart rate reduction before cardiac computed tomography?

Phase:

PHASE2

Details

Lead Sponsor:

Gdstrup Hospital

Collaborator:

Department of Cardiology, Gdstrup Hospital, Herning, Denmark

Treatments:

Atenolol
Ivabradine
Metoprolol